World The Vaccine Line Is Illogical
Why Israel’s Vaccine Success Might Be Hard to Replicate
A credible health-care system may be the key determinant to success.It’s the kind of standout success one would expect from the now-familiar stars of the global response to COVID-19—Taiwan, South Korea, or New Zealand. But it’s actually been achieved by Israel, in several respects a surprising country to be the world’s front-runner on vaccine distribution. A 2019 Johns Hopkins study ranked Israel an unspectacular 54th among 195 countries in terms of preparedness for a pandemic. After initially appearing to vanquish the coronavirus, Israel has since suffered some of the world’s worst outbreaks—something that remains true as it celebrates its vaccine advances.
In mid-January, I got an email telling me that I should schedule a visit to get my COVID-19 vaccination. I was a little surprised, as I am only 57 years old and didn’t think I qualified for the shot. I am also HIV-positive, but that shouldn’t move me ahead in line; my virus is well controlled on antiretroviral therapy, and my life expectancy is near normal. I am a professor at a public-health school, but that does not make me an essential worker. Meanwhile, my 86-year-old mother, who lives in New York, just one state over from where I live in Connecticut, is dutifully waiting for a call from her doctor’s medical network to tell her to come in for her first vaccine dose. I told her not to hang by the phone, as I doubted anyone would be calling soon.
California Hospitals Blame Poor Vaccine Rollout on Lack of Transparency From Government
Hospital officials in California argue vaccine rollouts across the nation were politicized by the former administration, but they are unsure if the Biden administration will be able to supply the vaccine the state desperately needs.But the delay has nothing to do with the state's health care systems, hospital officials told Newsweek. The issue stems from a lack of transparency from the federal government.
Vaccinations and medicines should be distributed equitably, but the neediest are seldom at the front of the line. Every state and every health-care provider has protocols that supposedly direct the first coronavirus vaccines to the people who need them most. Communities are moving down their list at different speeds and in different orders, but the definition of who goes next is being interpreted broadly.
In the earliest phase of the vaccine rollout, hospitals and medical schools were giving out, health-care workers who are far from the front lines of COVID-19 care, and even medical students, who are not on the wards. But now I’m seeing 30-somethings on my Facebook feed talking about their vaccinations, and others in their 40s and 50s taking their shots as well.
Covid: Why is EU’s vaccine rollout so slow?
The BBC's Katya Adler asks if the 27-member bloc's all-for-one and one-for-all approach has failed.As things stand, according to EU sources, the bloc looks sets to receive only a quarter of the 100 million doses it had been expecting from pharma company AstraZeneca by the end of March - putting millions of lives at risk.
It’s nearing the end of the month, and I still haven’t followed through to get my shot. I posed my dilemma to many colleagues—am I queue-jumping if I take the chance to get vaccinated now, when people at far greater risk of acquiring SARS-CoV-2 and getting seriously ill potentially haven’t been vaccinated yet? I also took the question to Twitter, where physicians and other health-care workers, ethicists, and members of the lay public urged me to take the opportunity to get vaccinated now. The reasons were compelling. In the chaos of the moment, with supplies low, just getting jabs into people’s arms is what is important. Vaccines shouldn’t go to waste. I would be contributing to herd immunity. My HIV status still presents some risk beyond that of others in my age cohort. Most of this, particularly the need to get as many people vaccinated as quickly as possible, is true.
The Differences Between Covid Vaccines by Johnson & Johnson, Moderna, Pfizer, Astrazeneca
Johnson & Johnson say their vaccine is 66 percent effective overall in preventing moderate to severe COVID-19.The Johnson & Johnson vaccine only requires one shot, which the company has said it will provide on a "non-profit" basis for the duration of the pandemic—costing around $10 a dose.
But I still don’t feel like the advantage given to me is fair. In the United States, we have far too much practice in ignoring the ethical dilemmas staring us in the face, and the coronavirus rollout continues deadly old patterns. In 16 states that release data on the demographics of vaccination, Black Americans are falling behind, while their white counterparts are being. Deaths from COVID-19 have and continue to , so even if people callously dismiss calls for racial equity, the epidemiological case stands on its own: Those at greater risk of getting COVID-19 and getting seriously ill are not being vaccinated first.
Zoom out further and the global scenario is catastrophic. Oxfam predicts thatin poor countries will not get vaccinated this year. Tedros Adhanom Ghebreyesus, the head of the World Health Organization, that more than 39 million vaccine doses had been given in 49 rich countries, but one poor nation—Guinea—had just 25 doses. Imagine if President Joe Biden or one of his counterparts in the G7 said that only 25 people could get even one dose.
Rejected contracts and a Hollywood movie - how UK struck deal to guarantee vaccine supply
As the row over vaccine supplies heated up this week, the UK government stuck to a simple line. © Reuters AstraZeneca partnered with Oxford - but it was close to being very different Ministers and officials repeatedly said they do not want conflict over vaccines. Yet, at the same time, they stated their confidence that they would get the doses they needed."We're very confident in our supplies, we're very confident in our contracts and we're going ahead on that basis," the prime minister declared on Wednesday. Behind the scenes, the message is the same.
Gallery: Dr. Fauci Just Said We'll Never Be Able to Do This Again (Best Life)
I spent most of my life researching HIV, much of it to expand access to AIDS treatment around the globe. All I can see right now is the world repeating the sad history of access to life-saving AIDS drugs. I am alive today because, when the treatment came out in the mid-1990s, I was able to get access to them, first in a clinical trial, then at the pharmacy with a prescription from my primary-care physician.
Access to antiretroviral medicines wasn’t even on the world’s agenda until the 21st century, when, politicians, and other leaders challenged rich nations to step up and address the obvious injustice. Initially they heard hemming and hawing about the frailty of health systems in the developing world; the need to focus on basic health care before thinking of such “fancy” interventions as antiretroviral therapy; and, in one of the most odious excuses, from the head of the U.S. Agency for International Development, a notion , which meant they’d never take their pills as scheduled on a daily basis. But activists in the global south persisted, with leaders including Nelson Mandela rebuking the rich nations of the world for leaving people to die.
The frustrating reality of having vaccine-hesitant family members
Some think misinformation contributed to their families’ skepticism about the Covid-19 vaccine.His parents, who are in their mid- to late 80s, live in senior apartments in a rural part of Wisconsin an hour from Milwaukee, where Carlson lives. Six people have contracted Covid-19 in their building, and three have died from it.
The inequities in the AIDS crisis don’t happen only abroad. In the U.S., the AIDS epidemic is roaring across the rural South, where one out of two—of—African American gay men are likely to be diagnosed with HIV in their lifetimes, compared with one in 11 white gay men.
The poor and the marginalized are always at the back of the line. For HIV, for COVID-19. But this is not destiny or fate. Many of the activists in the global south who pushed for access to antiretroviral therapy are at the forefront of this.
My South African friend and colleague Zackie Achmat, who is HIV-positive, said almost 20 years ago that heuntil his government made them freely accessible to the poor. He was mainly fighting back against President Thabo Mbeki, who blocked access to these drugs while in the thrall of conspiracy theories that suggested HIV didn’t cause AIDS and that the drugs were poison. However, Achmat was also taking a stand against drug developers that balked at price reductions and at allowing local companies to produce their medicines. Developers are taking similar stances today. Moderna, for example, has priced its mRNA vaccine as out of reach for and has prioritized access in high-income countries.
Companies and government inaction are standing in the way of progress. But let’s be clear: The cult of “me first”—whether it’s at the scale of nations hoarding vaccine doses; leaders ignoring the plight of the marginalized in their own backyards; or the mad, individual-level scramble to get a jab as soon as one can figure out how to—is the source of the problem.
Purchase of Russia’s COVID vaccine sparks debate in Iran
Public, health officials locked in a debate over Russian vaccine that is due to arrive in Iran on Thursday.Zarif was in Moscow as part of a diplomatic trip across the Caucasus when he announced the approval of Sputnik V for emergency use and said Iran aims to start co-producing the vaccine in the near future.
What needs to happen? First, the deficit Kabuki theater about how to shrink the pandemic relief bill needs to stop. America is going to need far more than what’s on the table now () to vanquish this plague. The past few weeks have also shown that inequity is built into distribution systems in the U.S. Instead of blaming the Trump administration’s failed rollout, the Biden administration needs to fix it. The National Academies of Sciences, Engineering, and Medicine have using the CDC’s with equity as a primary consideration.
Biden has said that he expects we’ll have enough doses to vaccinate all Americans by the, but he’s said nothing about my friends around the world who will watch us once again shove our way to the head of the line with barely a glance backward to see who is left behind. The U.S. needs to massively scale up the production of Moderna’s and Pfizer’s vaccines right now; they are potent and already in use. If these companies cannot make enough vaccine for the world—and they surely cannot— in the U.S. and in other countries that have domestic pharmaceutical capacity, such as South Africa, Brazil, and India.
I’m not asking you to give away your shot based on my own ethical dilemma. My delay in signing up for my vaccination might not persuade our political leaders to take equity more seriously than they have to date. If you have the opportunity to get vaccinated, don’t wait. Urge your friends, family, and colleagues to do the same.
But for me, watching history repeat itself is just too hard. I can’t simply roll up my sleeve and show my vaccination card as some trophy afterward. I’ll help my mother get the vaccination she needs. As for me? I’ll wait.
Vaccine diplomacy: China moves to fill gaps the West leaves behind .
This will be a blessing to many countries, but it also presents very real risks.Fed up with being left behind in the global COVID-19 response, nations in Latin America, Africa and the European Union (EU) have turned to new saviours: Russia and China.